Delivery Order SPE2DB22D2108-SPE2DB25FU2SX
Award Date
11/15/24
Potential Completion Date
11/18/24
Potential Value
$4.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This contract award, valued at $26,997.25, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the delivery of TWINRIX vaccine syringes, a vaccine used to prevent hepatitis A and hepatitis B. This is a firm-fixed-price delivery order contract with an ultimate completion date of August 5, 2024. The contract was not set aside for any specific business type. AmerisourceBergen holds a large Indefinite...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,818.87 firm fixed-price delivery order is for the supply of TWINRIX VACCINE SYRINGEML, a hepatitis A and hepatitis B vaccine. The contract has an ultimate completion date of March 24, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,821.67 fixed-price delivery order is for the supply of TWINRIX VACCINE SYRINGE ML, a hepatitis A and hepatitis B vaccine. The contract has a completion date of June 25, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $13,656.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TWINRIX vaccine syringes, a vaccine for Hepatitis A and Hepatitis B. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an Ultimate Completion Date of August 28, 2024. It is not designated as a Set-Aside contract, indicating open...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,050.76 firm fixed-price contract is for the delivery of TWINRIX VACCINE SYRINGEML, a hepatitis A and hepatitis B vaccine, to support defense medical requirements. The contract has a completion date of June 4, 2025 and is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a...
This federal contract award, valued at $65,550.72, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the supply of TWINRIX VACCINE SYRINGEML, a hepatitis A and hepatitis B vaccine. The contract has an ultimate completion date of June 11, 2024 and is a firm fixed-price contract. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $2,693.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TWINRIX Vaccine syringes, a vaccine used for the prevention of hepatitis A and hepatitis B. The contract type is a Delivery Order with a Firm Fixed Price pricing structure, and the ultimate completion date is April 18, 2023. This award is not designated as a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor to the U.S. federal government. The $2,704.32 firm fixed-price contract is for the supply of TWINRIX VACCINE SYRINGES, a hepatitis A and hepatitis B combination vaccine, with a completion date of September 4, 2024. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TWINRIX VACCINE SYRINGEML, a hepatitis A and B vaccine, at a ceiling value of $1,481.68. The contract has a firm fixed price pricing type and an ultimate completion date of March 13, 2025. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp is the prime...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $2,069.35 firm-fixed-price delivery order is for the supply of TWINRIX VACCINE SYRINGEML, a hepatitis A and hepatitis B vaccine. The contract has an ultimate completion date of August 5, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for providing a...